# Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

> **NCT00239733** · PHASE4 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 6 (actual)

## Conditions studied

- Thrombocytopenia
- Hepatitis C
- HIV Infections

## Interventions

- **DRUG:** Anti-D

## Key facts

- **NCT ID:** NCT00239733
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** failure to enroll additional subjects
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239733, "Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00239733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*